Exactech to Present to Investors at the
2012 Noble Financial Equity Conference  

GAINESVILLE, Fla. – Jan. 9, 2012 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced that President David Petty and Chief Financial Officer Jody Phillips will present at the Eighth Annual Noble Financial Equity Conference in Hollywood, Florida on Tuesday, January 17th at 10:00 a.m. EST.

The investor presentation will be webcast with streaming video and PowerPoint slides at http://www.hawkassociates.com/profile/exac.cfm. The SilverLight viewer is required (free download from the presentation link).

About Noble Financial
Noble Financial Capital Markets is an equity research driven, full-service investment banking boutique focused on small-cap, emerging growth companies. http://www.noblefcm.com

About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit http://www.exac.com for additional information about Exactech. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable investor information is available at http://www.exac.com and http://www.hawkassociates.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Investor contacts                                                                    Julie Marshall or Frank Hawkins
Jody Phillips                                                                            Hawk Associates
Chief Financial Officer                                                           305-451-1888
352-377-1140                                                                        E-mail: exactech@hawkassociates.com

Printable PDF